Aladdin Healthcare Technologies SE (ALDNF) Research

Aladdin Healthcare Technologies SE, operating through its subsidiary Aladdin Healthcare Technologies Ltd, develops advanced software solutions for the secure storage and management of health information, prominently featuring blockchain technology. The company's core competencies lie in cutting-edge fields such as blockchain, machine learning, and artificial intelligence. Among its innovative offerings is an Artificial Intelligence Early Diagnosis platform, utilizing AI for the sophisticated analysis of brain imaging. Another significant product is its Health Risk Assessment platform, designed to evaluate patients' susceptibility to cardiovascular, diabetic, and kidney-related conditions. Furthermore, Aladdin Healthcare Technologies is pioneering an Artificial Intelligence-assisted Drug Discovery platform, which aims to pinpoint novel small molecule drug compounds for a range of age-related illnesses, including Alzheimer's and Parkinson's, as well as SARS-CoV-2. Leveraging blockchain, machine learning, artificial intelligence, and advanced predictive data analytics, the company is committed to facilitating the early detection of chronic diseases. Established in 2014, Aladdin Healthcare Technologies SE is headquartered in Berlin, Germany.

Open Aladdin Healthcare Technologies SE (ALDNF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.